期刊文献+

多囊卵巢综合征合并胰岛素抵抗患者脂肪组织中磷脂酰肌醇3激酶的检测及其意义 被引量:1

Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance
原文传递
导出
摘要 目的检测多囊卵巢综合征(PCOS)合并胰岛素抵抗(IR)患者脂肪组织中磷脂酰肌醇3激酶(PI-3K)的表达,探讨PCOS患者发生IR的机制。方法检测PCOS发生IR 19例患者(PCOS IR组)、PCOS未发生IR 10例患者(PCOS非IR组)及因单纯子宫肌瘤施行手术的15例患者(对照组)的空腹血清胰岛素(FIN)及空腹血糖(FPG)的水平。采用稳态模型(HOMA)法评价及计算IR指数(HOMA-IR);采用蛋白印迹法检测脂肪组织中PI-3K蛋白的表达;采用RT-PCR技术检测PI-3K mRNA的表达;采用免疫沉淀技术、薄层层析及γ液体闪烁计数仪检测PI-3K的活性,设对照组平均PI-3K活性为100%。结果(1)PCOS IR组患者血清FIN为(25.2±3.8)mU/L,HOMA-IR为1.6±0.3;PCOS非IR组分别为(13.4±3.8)mU/L及0.9±0.3;对照组分别为(9.5±2.6)mU/L及0.5±0.3,3组分别比较,差异均有统计学意义(P<0.05)。(2)PCOS IR组PI-3K蛋白及mRNA相对表达水平分别为0.65±0.10及0.92±0.12;PCOS非IR组分别为0.72±0.10及1.01±0.10;对照组分别为0.73±0.14及1.00±0.12,3组分别比较,差异均无统计学意义(P>0.05)。(3)PCOS IR组PI- 3K活性下降为81%,PCOS非IR组下降为89%,PCOS IR组及PCOS非IR组分别与对照组比较,差异均有统计学意义(P<0.01,P<0.05)。PCOS IR组和PCOS非IR组PI-3K活性与HOMA-IR均呈显著负相关关系(r=-0.69,P<0.01;r=-0.62,P<0.05)。结论PCOS IR患者的PI-3K蛋白及mRNA的表达无明显改变,但PCOS患者PI-3K活性降低,可能是PCOS患者发生IR的机理之一。 Objective To investigate the expression of phosphatidylinositol 3-kinase (PI-3K) in adipose tissue of polycystic ovary syndrome patients (PCOS) , and explore molecular mechanisms of insulin resistance (IR) in PCOS. Methods Samples from patients with PCOS with IR ( n = 19 ), PCOS without IR (n = 10) and controls (n = 15)were collected. Serum fasting insulin (FIN) and fasting plasma glucose (FPG) were measured. Insulin resistance index was calculated using homeostasis model assessment (HOMA) to analyze the relationship between these markers and IR. Western blot technique was used to detect the PI-3K p85 subunit. Gene expression of PI-3K p85 subunit was detected by reverse transcription polymerase chain reaction (RT-PCR) method. Kinase activity was detected by immunoprecipitation, thinlayer chromatography and gamma scintillation counting. Results ( 1 ) The levels of FIN [ ( 25.2 ± 3.8 ) mU/L] and HOMA-IR( 1.6 ±0. 3) in PCOS with IR were significantly higher than those in PCOS without IR [(13.4 ±3.8)mU/L,0.9 ±0.3] and controls [(9.5 ±2.6)mU/L,0.5 ±0.3; all P〈0.05). (2) There was no significant difference in the protein(0. 65 ±0. 10) and gene expression (0. 92±0. 12) of PI-3K p85 subunit in PCOS with IR compared with PCOS without IR (0. 72 ± 0. 10, 1.01 ± 0. 10) and controlgroups (0. 73 ± 0. 14,1.00 ± 0. 12 ; P 〉 0. 05 ). ( 3 ) PI-3K activity in PCOS with IR ( 81% ) and PCOS without IR (89%) was significantly decreased (P 〈 0. 01, P 〈 0.05 ) and negatively correlated with HOMA- IR (r= -0.69,P〈0.01;r= -0.62,P〈0.05). Conclusions No significant difference in the protein and gene expression of PI-3K p85 subunit in PCOS with IR is found. The decreased PI-3K activity may lead to IR of PCOS.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2006年第7期455-458,共4页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金(30100200)
关键词 多囊卵巢综合征 胰岛素抗药性 脂肪组织 1-磷脂酰肌醇3-激酶 Polycystic ovary syndrome Insulin resistance Adipose 1 -Phosphatidylinositol 3-kinase
  • 相关文献

参考文献7

  • 1Marsden PJ, Murdoch AP, Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol (Oxf),2001,55:191-199.
  • 2Meyer C, McGrath BP, Teede HJ, et al. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocfinol Metab, 2005,90:5711-5716.
  • 3李儒芝,林金芳,周剑萍.二甲双胍治疗高胰岛素血症所致无排卵的临床观察[J].中华妇产科杂志,2001,36(5):296-298. 被引量:15
  • 4Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetulogia,1985,28:412-419.
  • 5Orio F Jr, Palomba S, Cascella T, et al. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with pulycystic ovary syndrome: results of a 6-month study. J Clin Endocrinol Metab, 2005,90:6072-6076.
  • 6Kim YB, Peroni OD, Aschenbach WG, et al. Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism. Mol Cell Biol,2005,25:9713-9723.
  • 7初永丽,孙永玉,邱红玉,李红发.胰岛素受体底物1蛋白表达及其酪氨酸磷酸化程度与多囊卵巢综合征发病的关系[J].中华妇产科杂志,2004,39(3):176-179. 被引量:15

二级参考文献6

  • 1王颖,中华妇产科杂志,2000年,35卷,594页
  • 2Qin K N,Mol Cell Endocrinol,1998年,145卷,111页
  • 3Nestler J E,New Engl J Med,1998年,338卷,1876页
  • 4Velazquez E M,Metabolism,1994年,43卷,647页
  • 5Kiddy D S,Clin Endocrinol,1992年,36卷,105页
  • 6王颖,李美芝,赵一鸣.预测多囊卵巢综合征促排卵治疗结局的研究[J].中华妇产科杂志,2000,35(10):594-596. 被引量:12

共引文献28

同被引文献19

  • 1蒋奕,吴国豪.大鼠创伤后胰岛素抵抗与胰岛素信号转导关系的研究[J].中华普通外科杂志,2007,22(4):284-287. 被引量:6
  • 2Park SY, Choi GH, Choi HI, et al. Depletion of mitochondrial DNA causes impaired glucose utilization and Insulin Resistance in L6 GLUT4myc myocytes. Biological Chemistry. 2005;280(11 ): 9855-9864.
  • 3Ogihara T, Asano T, Ando K, et al. Angiotensin Ⅱ -induced insulin resistance is associated with enhanced insulin signaling. Hypertension. 2002;40(6):872-879.
  • 4Cho H, Mu J, Kim JK, et al. Insulin resistane and a diabete melLitus-like syndrome in mice lacking the Protein kinase Akt2 (DKBbeta). Science. 2001:292(5522): 1728-1731.
  • 5Duplain H, Sartori C, Dessen P, et al. Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet-fed mice. Physiol. 2008;586(16):4011-4016.
  • 6Alfredo Csibi, David Communi, Nathalie Muller, et aL Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS ONE, 2010;5(4):e10070.
  • 7MacLean PS, Zheng D, Jones JP, et al. Exercise-inducedtranscription of the muscle glucose transporter (GLUT4) gene. Biochem Biophys Res Commun. 2002;292(2): 409-414.
  • 8Bernard JR, Reeder DW, Herr H J, et al. High-fat feeding effects on components of the CAP/Cbl signaling cascade in Sprague-Dawley rat skeletal muscle. Metabolism. 2006;55(2): 203-212.
  • 9Prada PO, Pauli JO, Ropelle ER, et al. Selective modulation of the CAP/Cbl pathway in the adipose tissue of high fat diet treated rats. FEBS Lett. 2006;580(20):4889-4894.
  • 10Liu L, Zhang Y, Chen N, et al. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest. 2007;117(6): 1679-1689.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部